Recently, I discussed a couple of reports that have come to light, potentially exposing the shortcomings of an FDA policy on “fast tracking” the approval of certain new drugs. Now, the FDA is in the middle of a large operation to remedy other policy issues…
Every time you turn on the television, you are most likely bombarded by a barrage of advertisements for prescription drugs. While you might be wary of marketer’s claims and promises as to their effect, you can at least rest assured that all have passed stringent…
Currently, knee surgery is the most prevalent procedure performed on patients aged 45 years and older – totaling about 600,000 procedures in the U.S. and growing. Unfortunately, the increase in surgeries also brings with it an increase in knee replacement complaints, problems and even failures.…
In 2014, A young woman in Snellville, Georgia visited her doctor with claims of depression. Her physician prescribed lamotrigine, also marketed under the tradename Lamictal, a mood-stabilizing anticonvulsant best known for controlling seizures with those who suffer from epilepsy. While the medicatio
In the third consecutive talcum powder trial, a St. Louis City jury award plaintiff Deborah Giannecchini $2.57 million in compensatory damages and 67.5 million in punitive damages against Johnson & Johnson and the Imerys Talc America defendants for their talc-containing personal hygiene product. Per
CSS Firm is no longer accepting new Stryker LFIT V40 Hip Implant Claims. Any information on this page or website is for educational purposes only. Last week Childers, Schlueter & Smith, LLC published the Australian Health Hazard alert regarding the Stryker LFIT V40 Femoral head. …
The FDA just released more information on Invokana and Farxiga related to acute kidney failure. A topic and drug Childers, Schlueter & Smith have been investigating for a long time now. Check out our: Top 10 Things Invokana Patients Need To Know… As…
An Invokana lawsuit filed last year in Canada seeks $1 billion in damages against drug maker Janssen Pharmaceuticals. The lawsuit, filed in September 2015 at the Ontario Superior Court of Justice, seeks class-action status, which is expected to be determined within the next six or…
The diabetes drug Invokana was introduced to the U.S. market in March 2013 and quickly became the go-to type 2 diabetes treatment, although the safety of the medication became a point of contention relatively quickly. In May 2015, the Institute for Safe Medication Practices released…
Although federal law requires the reporting of adverse events, no reports concerning power morcellators had been received by the U.S. Food and Drug Administration (FDA) prior to December 2013, according to The Cancer Letter. Prior to December 2013, the FDA had received no Medical Device…
According to a case management order issued by U.S. District Judge Eldon Fallon, 40 cases will be chosen for the Xarelto bellwether pool, with each side selecting 10 cases and an additional 20 chosen randomly. According to Judge Fallon’s plan: Half of the cases will…
A medical study published in the October 2015 issue of the Annals of Surgery takes a closer look at whether trauma patients actually benefit from having inferior vena cava (IVC) filters implanted, or instead face a greater risk of life-threatening complications associated with the filters…
